IAPAM Best Practices for the Injection of Botox (Botulinum Toxin Type A)

.

Introduction - Botox (Botulinum Toxin Type A)

Since first introduced to the medical community in 1989, as a treatment for eye muscle disorders, administering of Botulinum Toxin Type A: Botox® and similar neurotoxin injectables, has now become the most popular non-invasive aesthetic medical procedure performed worldwide.

Unfortunately, such pervasive market growth has lead to the undesired reality that physicians and non-medical professionals mistakenly think that all they need to do to capture a percentage of this market for their practice, is to simply hang out a sign and ’start injecting.’ Read more